Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
about
Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.Skeletal Muscle MicroRNAs: Their Diagnostic and Therapeutic Potential in Human Muscle Diseases.Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy.Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis.Extracellular Vesicle MicroRNA Transfer in Lung Diseases.Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice.
P2860
Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
@en
type
label
Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
@en
prefLabel
Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
@en
P2860
P356
P1476
Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
@en
P2093
Tyler Calway
P2860
P304
P356
10.1177/1074248414552902
P50
P577
2014-09-26T00:00:00Z